Reagents for Quantitative Determination of Catalytic Activity of Myocardial Isoenzyme Creatine Kinase (CK-MB) by Enzymatic Spectrophotometric Analysis in Serum and Plasma on Biochemical Analyzers and Modular Platforms Roche

Reagents for Quantitative Determination of Catalytic Activity of Myocardial Isoenzyme Creatine Kinase (CK-MB) by Enzymatic Spectrophotometric Analysis in Serum and Plasma on Biochemical Analyzers and Modular Platforms Roche

Reagents for Quantitative Determination of CK-MB

Available formats:

• Reagents in a cassette (CKMB/Creatine Kinase-MB for Cobas Integra/cobas c systems)
• Reagents in vials (CKMB/Creatine Kinase-MB for cobas c 111)

Composition:

• Reagent R1 in a vial, 2 units
• Reagent SR in a vial, 2 units

Instructions for use: Included

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagents for Quantitative Determination of Catalytic Activity of Myocardial Isoenzyme Creatine Kinase (CK-MB) by Enzymatic Spectrophotometric Analysis in Serum and Plasma on Biochemical Analyzers and Modular Platforms Roche, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.